Journal of Clinical Oncology, Vol 21, Issue 6
(March), 2003: 1174-1179
© 2003 American Society for Clinical Oncology
Role of DNA Mismatch Repair Defects in the Pathogenesis of Human Cancer
Päivi Peltomäki
From the Department of Medical Genetics, University of Helsinki, Finland; and Division of Human Cancer Genetics, The Ohio State University, Columbus, OH.
Address reprint requests to Päivi Peltomäki, MD, Department of Medical Genetics, Biomedicum Helsinki, P.O. Box 63 (Haartmaninkatu 8), FIN-00014 University of Helsinki, Finland; email: paivi.peltomaki{at}helsinki.fi.
The DNA mismatch repair (MMR) system is necessary for the maintenance of genomic stability. In a broad sense, all main functions of the MMR system, including the correction of biosynthetic errors, DNA damage surveillance, and prevention of recombination between nonidentical sequences serve this important purpose. Failure to accomplish these functions may lead to cancer. It is therefore not surprising that inherited defects in the MMR system underlie one of the most prevalent cancer syndromes in humans, hereditary nonpolyposis colon cancer (HNPCC). In addition, acquired defects of the same system may account for 15% to 25%, or even a higher percentage, of sporadic cancers of different organs of the "HNPCC spectrum," including the colon and rectum, uterine endometrium, stomach, and ovaries. Recent studies indicate that the MMR genes may be involved in the pathogenesis of even a broader spectrum of tumors in one way or another. An updated review of the different features of the human MMR system will be provided, with the emphasis on their implications in cancer development.
Supported by grants from the Sigrid Juselius Foundation, Academy of Finland, Finnish Cancer Foundation, and the National Institutes of Health (CA82282).
This article has been cited by other articles:
|
|
|
|
 
A.H.S. Gylling, T.T. Nieminen, W.M. Abdel-Rahman, K. Nuorva, M. Juhola, E.I. Joensuu, H.J. Jarvinen, J.-P. Mecklin, M. Aarnio, and P.T. Peltomaki
Differential cancer predisposition in Lynch syndrome: insights from molecular analysis of brain and urinary tract tumors
Carcinogenesis,
July 1, 2008;
29(7):
1351 - 1359.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. I. Joensuu, W. M. Abdel-Rahman, M. Ollikainen, S. Ruosaari, S. Knuutila, and P. Peltomaki
Epigenetic Signatures of Familial Cancer Are Characteristic of Tumor Type and Family Category
Cancer Res.,
June 15, 2008;
68(12):
4597 - 4605.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I.-Y. Chang, M. Jin, S. P. Yoon, C.-K. Youn, Y. Yoon, S.-P. Moon, J.-W. Hyun, J. Y. Jun, and H. J. You
Senescence-Dependent MutS{alpha} Dysfunction Attenuates Mismatch Repair
Mol. Cancer Res.,
June 1, 2008;
6(6):
978 - 989.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. P. Martin, T. C. Hamilton, and R. J. Schilder
Platinum Resistance: The Role of DNA Repair Pathways
Clin. Cancer Res.,
March 1, 2008;
14(5):
1291 - 1295.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Z. J. Chu, G. Gibson, D. David, and Y. Yen
The Surgeon's Role in Cancer Prevention. The Model in Colorectal Carcinoma
Ann. Surg. Oncol.,
November 1, 2007;
14(11):
3054 - 3069.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. E. Gammie, N. Erdeniz, J. Beaver, B. Devlin, A. Nanji, and M. D. Rose
Functional Characterization of Pathogenic Human MSH2 Missense Mutations in Saccharomyces cerevisiae
Genetics,
October 1, 2007;
177(2):
707 - 721.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. M. Harrington and R. D. Kolodner
Saccharomyces cerevisiae Msh2-Msh3 Acts in Repair of Base-Base Mispairs
Mol. Cell. Biol.,
September 15, 2007;
27(18):
6546 - 6554.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. S. Shewach and T. S. Lawrence
Antimetabolite Radiosensitizers
J. Clin. Oncol.,
September 10, 2007;
25(26):
4043 - 4050.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. S. F. Biard
Untangling the relationships between DNA repair pathways by silencing more than 20 DNA repair genes in human stable clones
Nucleic Acids Res.,
June 28, 2007;
35(11):
3535 - 3550.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. L. Mendillo, C. D. Putnam, and R. D. Kolodner
Escherichia coli MutS Tetramerization Domain Structure Reveals That Stable Dimers but Not Tetramers Are Essential for DNA Mismatch Repair in Vivo
J. Biol. Chem.,
June 1, 2007;
282(22):
16345 - 16354.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. V. Seiden, D. Patel, M. J. O'Neill, and E. Oliva
Case 13-2007 -- A 46-Year-Old Woman with Gynecologic and Intestinal Cancers
N. Engl. J. Med.,
April 26, 2007;
356(17):
1760 - 1769.
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. O. Knudsen, F. C. Nielsen, L. Vinther, R. Bertelsen, S. Holten-Andersen, S. E. Liberti, R. Hofstra, K. Kooi, and L. J. Rasmussen
Nuclear localization of human DNA mismatch repair protein exonuclease 1 (hEXO1)
Nucleic Acids Res.,
April 10, 2007;
(2007)
gkl1166v1.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. A. Talseth, C. Meldrum, J. Suchy, G. Kurzawski, J. Lubinski, and R. J. Scott
Genetic Polymorphisms in Xenobiotic Clearance Genes and Their Influence on Disease Expression in Hereditary Nonpolyposis Colorectal Cancer Patients.
Cancer Epidemiol. Biomarkers Prev.,
November 1, 2006;
15(11):
2307 - 2310.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Song, S. J. Ramus, L. Quaye, R. A. DiCioccio, J. Tyrer, E. Lomas, D. Shadforth, E. Hogdall, C. Hogdall, V. McGuire, et al.
Common variants in mismatch repair genes and risk of invasive ovarian cancer
Carcinogenesis,
November 1, 2006;
27(11):
2235 - 2242.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Modrich
Mechanisms in Eukaryotic Mismatch Repair
J. Biol. Chem.,
October 13, 2006;
281(41):
30305 - 30309.
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Lanza, R. Gafa, A. Santini, I. Maestri, L. Guerzoni, and L. Cavazzini
Immunohistochemical Test for MLH1 and MSH2 Expression Predicts Clinical Outcome in Stage II and III Colorectal Cancer Patients
J. Clin. Oncol.,
May 20, 2006;
24(15):
2359 - 2367.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M Filipic, T Fatur, and M Vudrag
Molecular mechanisms of cadmium induced mutagenicity
Human and Experimental Toxicology,
February 1, 2006;
25(2):
67 - 77.
[Abstract]
[PDF]
|
|
|
|
|
|
|
E. J. Fox, D. T. Leahy, R. Geraghty, H. E. Mulcahy, D. Fennelly, J. M. Hyland, D. P. O'Donoghue, and K. Sheahan
Mutually Exclusive Promoter Hypermethylation Patterns of hMLH1 and O6-Methylguanine DNA Methyltransferase in Colorectal Cancer
J. Mol. Diagn.,
February 1, 2006;
8(1):
68 - 75.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. T. Hess, M. L. Mendillo, D. J. Mazur, and R. D. Kolodner
Biochemical basis for dominant mutations in the Saccharomyces cerevisiae MSH6 gene
PNAS,
January 17, 2006;
103(3):
558 - 563.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Boyd
Genetic Basis of Familial Endometrial Cancer: Is There More to Learn?
J. Clin. Oncol.,
July 20, 2005;
23(21):
4570 - 4573.
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. L. Mendillo, D. J. Mazur, and R. D. Kolodner
Analysis of the Interaction between the Saccharomyces cerevisiae MSH2-MSH6 and MLH1-PMS1 Complexes with DNA Using a Reversible DNA End-blocking System
J. Biol. Chem.,
June 10, 2005;
280(23):
22245 - 22257.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. M. Baudhuin, M. Mai, A. J. French, K. E. Kruckeberg, R. L. Swanson, J. L. Winters, L. K. Courteau, and S. N. Thibodeau
Analysis of hMLH1 and hMSH2 Gene Dosage Alterations in Hereditary Nonpolyposis Colorectal Cancer Patients by Novel Methods
J. Mol. Diagn.,
May 1, 2005;
7(2):
226 - 235.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Offman, K. Gascoigne, F. Bristow, P. Macpherson, M. Bignami, I. Casorelli, G. Leone, L. Pagano, S. Sica, O. Halil, et al.
Repeated Sequences in CASPASE-5 and FANCD2 but not NF1 Are Targets for Mutation in Microsatellite-Unstable Acute Leukemia/Myelodysplastic Syndrome
Mol. Cancer Res.,
May 1, 2005;
3(5):
251 - 260.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. W.F. Catto, A.-R. Azzouzi, I. Rehman, K. M. Feeley, S. S. Cross, N. Amira, G. Fromont, M. Sibony, O. Cussenot, M. Meuth, et al.
Promoter Hypermethylation Is Associated With Tumor Location, Stage, and Subsequent Progression in Transitional Cell Carcinoma
J. Clin. Oncol.,
May 1, 2005;
23(13):
2903 - 2910.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Banerjee and H. Flores-Rozas
Cadmium inhibits mismatch repair by blocking the ATPase activity of the MSH2-MSH6 complex
Nucleic Acids Res.,
March 3, 2005;
33(4):
1410 - 1419.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R Naidoo, A Ramburan, A Reddi, and R Chetty
Aberrations in the mismatch repair genes and the clinical impact on oesophageal squamous carcinomas from a high incidence area in South Africa
J. Clin. Pathol.,
March 1, 2005;
58(3):
281 - 284.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Popat, R. Hubner, and R.S. Houlston
Systematic Review of Microsatellite Instability and Colorectal Cancer Prognosis
J. Clin. Oncol.,
January 20, 2005;
23(3):
609 - 618.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Lepourcelet, L. Tou, L. Cai, J.-i. Sawada, A. J. F. Lazar, J. N. Glickman, J. A. Williamson, A. D. Everett, M. Redston, E. A. Fox, et al.
Insights into developmental mechanisms and cancers in the mammalian intestine derived from serial analysis of gene expression and study of the hepatoma-derived growth factor (HDGF)
Development,
January 15, 2005;
132(2):
415 - 427.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W Kievit, J H F M de Bruin, E M M Adang, J L Severens, J H Kleibeuker, R H Sijmons, T J Ruers, F M Nagengast, H F A Vasen, J H J M van Krieken, et al.
Cost effectiveness of a new strategy to identify HNPCC patients
Gut,
January 1, 2005;
54(1):
97 - 102.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L.R. Lipton, V. Johnson, C. Cummings, S. Fisher, P. Risby, A.T. Eftekhar Sadat, T. Cranston, L. Izatt, P. Sasieni, S.V. Hodgson, et al.
Refining the Amsterdam Criteria and Bethesda Guidelines: Testing Algorithms for the Prediction of Mismatch Repair Mutation Status in the Familial Cancer Clinic
J. Clin. Oncol.,
December 15, 2004;
22(24):
4934 - 4943.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Seo, T. Yan, J. E. Schupp, V. Colussi, K. L. Taylor, and T. J. Kinsella
Differential Radiosensitization in DNA Mismatch Repair-Proficient and -Deficient Human Colon Cancer Xenografts with 5-Iodo-2-pyrimidinone-2'-deoxyribose
Clin. Cancer Res.,
November 15, 2004;
10(22):
7520 - 7528.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Yan, A. B. Desai, J. W. Jacobberger, R. M. Sramkoski, T. Loh, and T. J. Kinsella
CHK1 and CHK2 are differentially involved in mismatch repair-mediated 6-thioguanine-induced cell cycle checkpoint responses
Mol. Cancer Ther.,
September 1, 2004;
3(9):
1147 - 1157.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. E. Liberti and L. J. Rasmussen
Is hEXO1 a Cancer Predisposing Gene?
Mol. Cancer Res.,
August 1, 2004;
2(8):
427 - 432.
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Chen, O. K. Arseven, and V. L. Cryns
Proteolysis of the Mismatch Repair Protein MLH1 by Caspase-3 Promotes DNA Damage-induced Apoptosis
J. Biol. Chem.,
June 25, 2004;
279(26):
27542 - 27548.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Plaschke, S. Kruger, B. Jeske, F. Theissig, F. R. Kreuz, S. Pistorius, H. D. Saeger, I. Iaccarino, G. Marra, and H. K. Schackert
Loss of MSH3 Protein Expression Is Frequent in MLH1-Deficient Colorectal Cancer and Is Associated with Disease Progression1
Cancer Res.,
February 1, 2004;
64(3):
864 - 870.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M.-E. Huang, A.-G. Rio, A. Nicolas, and R. D. Kolodner
A genomewide screen in Saccharomyces cerevisiae for genes that suppress the accumulation of mutations
PNAS,
September 30, 2003;
100(20):
11529 - 11534.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
